PVP Labs to present Taphalgin®, a first-in-class non-addictive analgesic, and advanced peptide drug platform at LSX Investival Showcase USA in Miami.
The FDA defines acute pain as pain, lasting up to 30 days, typically in response to some form of tissue injury, such as trauma or surgery. In an effort to further combat the opioid crisis, the Food ...
Clinical trials of a novel non-opioid analgesic have found it to be effective in reducing acute postoperative pain, opening the door to a new way of managing short-term pain that avoids the pitfalls ...
Share on Pinterest A recent study used computational methods to identify novel compounds that activate receptors involved in pain modulation without sedation. Peter Dazeley/Getty Images Research on ...
DUBLIN, Feb. 17, 2021 /PRNewswire/ -- The "Analgesics Global Market Report 2020-30: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. The global analgesics ...
KIMM develops technology for a sensor to measure low flow rate and bubbles during drug infusion. Mass production of the world's first safe electric drug infusion pump equipped with a flow sensor is in ...
Day-to-day painkiller use doesn't lower empathy levels, but misuse might, according to recent survey
Empathy is fundamental in human social behavior, and analgesics are one of the most commonly consumed drugs globally. Research has shown that analgesic intake can reduce compassion in human beings. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results